BillionToOne, Inc. (NASDAQ:BLLN) shares traded higher premarket on possible continued momentum Tuesday before flattening at the beginning of the session. The company reiterated its fiscal-year 2025 guidance and initiated fiscal-year 2026 financial guidance on Monday.
BillionToOne’s Growth Trajectory Is Unprecedented
BillionToOne reiterated full-year 2025 revenue guidance in the range of $293 million to $299 million and said it expects to generate positive GAAP operating income for the year.
The company also introduced full-year 2026 guidance, projecting total revenue of $415 million to $430 million. The outlook represents growth of approximately 40% to 45% compared to the midpoint of the company’s 2025 guidance range. BillionToOne said it expects to deliver positive GAAP operating income for the full year 2026 as well.
BillionToOne said the 2026 outlook reflects its plans to continue scaling its platform through disciplined execution and a focused roadmap aimed at addressing clinical challenges.
BillionToOne Shares Soar During Early Trading
BLLN Price Action: At the time of writing, BillionToOne shares are slightly down at 0.14% lower at $99.01, according to data from Benzinga Pro.
This illustration was generated using artificial intelligence via Midjourney.
Recent Comments